Plasmid-controlled mercury biotransformation by Clostridium cochlearium T-2.

Por Pan-Hou, H S, Hosono, M, Imura, N
Publicado em 1980

The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis

Por Sun D, Hou H, Zhang C, Zhang X
Publicado em 2018-10-01

Scalable in silico Simulation of Transdermal Drug Permeability: Application of BIOiSIM Platform

Por Maharao N, Antontsev V, Hou H, Walsh J, Varshney J
Publicado em 2020-06-01

High Temperature Terahertz Detectors Realized by a GaN High Electron Mobility Transistor

Por Hou, H. W., Liu, Z., Teng, J. H., Palacios, T., Chua, S. J.
Publicado no Sci Rep (2017)

Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’

Por Hou, H-A, Lin, L-I, Chen, C-Y, Tien, H-F
Publicado em 2009

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non- small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy

Por Zhuang H, Hou H, Yuan Z, Wang J, Pang Q, Zhao L, Wang P
Publicado em 2014-05-01

Elastase induced lung epithelial cell apoptosis and emphysema through placenta growth factor

Por Hou, H-H, Cheng, S-L, Liu, H-T, Yang, F-Z, Wang, H-C, Yu, C-J
Publicado em 2013

Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish

Por Lu, J-W, Hsieh, M-S, Hou, H-A, Chen, C-Y, Tien, H-F, Lin, L-I
Publicado no Blood Cancer J (2017)

The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis

Por Hou H, Sun D, Liu K, Jiang M, Liu D, Zhu J, Zhou N, Cong J, Zhang X
Publicado em 2019-05-01

Concurrent TP53 mutations predict poor outcomes of EGFR-TKI treatments in Chinese patients with advanced NSCLC

Por Hou H, Qin K, Liang Y, Zhang C, Liu D, Jiang H, Liu K, Zhu J, Lv H, Li T, Zhang X
Publicado em 2019-06-01

Quinoid radio-toxin (QRT) induced metabolic changes in mice: An ex vivo and in vivo EPR investigation

Por Ibragimova, M.I., Petukhov, V.Yu., Zheglov, E.P., Khan, N., Hou, H., Swartz, H.M., Konjukhov, G.V., Nizamov, R.N.
Publicado em 2008

Specific antibody binding to the APP(672–699) region shifts APP processing from α- to β-cleavage

Por Li, S, Deng, J, Hou, H, Tian, J, Giunta, B, Wang, Y, Sawmiller, D, Smith, A, Sanberg, P R, Obregon, D, Mori, T, Tan, J
Publicado no Cell Death Dis (2014)

CD40L disruption enhances Aβ vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation

Por Obregon, D., Hou, H., Bai, Y., Nikolic, W.V., Mori, T., Luo, Deyan, Zeng, J., Ehrhart, J., Fernandez, F., Morgan, D., Giunta, B., Town, T., Tan, J.
Publicado em 2007

Skeletal Muscle Oxygenation Measured by EPR Oximetry Using a Highly Sensitive Polymer-Encapsulated Paramagnetic Sensor

Por Hou, H., Khan, N., Nagane, M., Gohain, S., Chen, E. Y., Jarvis, L. A., Schaner, P. E., Williams, B. B., Flood, A. B., Swartz, H. M., Kuppusamy, P.
Publicado no Adv Exp Med Biol (2016)

Evidence of s-wave superconductivity in the noncentrosymmetric La(7)Ir(3)

Por Li, B., Xu, C. Q., Zhou, W., Jiao, W. H., Sankar, R., Zhang, F. M., Hou, H. H., Jiang, X. F., Qian, B., Chen, B., Bangura, A. F., Xu, Xiaofeng
Publicado no Sci Rep (2018)

Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia

Por Hou, H-A, Kuo, Y-Y, Liu, C-Y, Lee, M C, Tang, J-L, Chen, C-Y, Chou, W-C, Huang, C-F, Lee, F-Y, Liu, M-C, Yao, M, Tien, H-F
Publicado em 2011

High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes

Por Cheng, C-L, Hou, H-A, Jhuang, J-Y, Lin, C-W, Chen, C-Y, Tang, J-L, Chou, W-C, Tseng, M-H, Yao, M, Huang, S-Y, Ko, B-S, Hsu, S-C, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Publicado em 2011

Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia

Por Hou, H-A, Lu, J-W, Lin, T-Y, Tsai, C-H, Chou, W-C, Lin, C-C, Kuo, Y-Y, Liu, C-Y, Tseng, M-H, Chiang, Y-C, Peng, Y-L, Tang, J-L, Gong, Z, Lin, L-I, Tien, H-F
Publicado no Blood Cancer J (2017)

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome

Por Chen, T-C, Hou, H-A, Chou, W-C, Tang, J-L, Kuo, Y-Y, Chen, C-Y, Tseng, M-H, Huang, C-F, Lai, Y-J, Chiang, Y-C, Lee, F-Y, Liu, M-C, Liu, C-W, Liu, C-Y, Yao, M, Huang, S-Y, Ko, B-S, Hsu, S-C, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Publicado em 2014

TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution

Por Hou, H-A, Chou, W-C, Kuo, Y-Y, Liu, C-Y, Lin, L-I, Tseng, M-H, Chiang, Y-C, Liu, M-C, Liu, C-W, Tang, J-L, Yao, M, Li, C-C, Huang, S-Y, Ko, B-S, Hsu, S-C, Chen, C-Y, Lin, C-T, Wu, S-J, Tsay, W, Chen, Y-C, Tien, H-F
Publicado no Blood Cancer J (2015)